Comparative Bioavailability of TNX-102 and Cyclobenzaprine and Effect of Food on the Pharmacokinetics of TNX-102 in Healthy Adults
Condition: HealthyInterventions: Drug: TNX-102 2.4 mg, Fasting conditions; Drug: TNX-102 2.4 mg, Fed conditions; Drug: Cyclobenzaprine 5 mg, Fasting conditionsSponsor: Tonix Pharmaceuticals, Inc.Completed - verified September 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cyclobenzaprine | Research